Super-Specialty Segment Pharma Distributor Raising Funds
Email
Phone
Google
LinkedIn
Facebook
About Business
The company operates as a pharmaceutical distributor for their products. It currently manages a portfolio of approximately 40 SKUs and is actively strengthening its brand presence under a registered trademark. The business focuses on the super-specialty segment, particularly in orthopedics, with an emphasis on osteoporosis and osteoprosthetic solutions.
The products are manufactured by WHO and USFDA-approved facilities, including established manufacturers such as Intas and other reputed partners. These products are marketed under the company’s own brand name.
The company has built a sales and marketing team of around 50 professionals operating across India, primarily in major metro and key cities.
Founded in 2022, the company began receiving inventory in early 2023 and has been actively operating in the market for the past three years. The business has demonstrated strong growth momentum, starting with revenue of approximately INR 1.15 crore and projecting around INR 4.5 crore in FY26.
In addition, the company has recently expanded into the chronic wound management segment by introducing five SKUs sourced from Collagen Healthcare, based in Salem.
Looking ahead, the company projects conservative revenues of approximately INR 12 crore for FY26–27 and is currently raising INR 2 crore to support further growth and expansion.
Clientele type
They cater to superspeciality(orthopedics) hospitals across India.
Premises
The premises are leased.
Asking Price Includes
The terms of the transaction will be discussed with suitable investors.
Asking Price
INR 2.00 Cr
Minimum ticket size
INR 2.00 Cr
Reason
They are raising funds to fuel the growth of the business and also introduce new products.
Keywords
Business Tags
Fundraising for ₹10 Cr – 500 Cr
Confidential Process Completed in 120 Days
Strategic Preparation, Aligned Investor Outreach and Seamless Closure
Supported by Advisors with 26+ Years of Experience
